ProtoKinetix, Incorporated (PKTX)
OTCMKTS · Delayed Price · Currency is USD
0.0064
-0.0001 (-1.54%)
Jan 23, 2026, 11:11 AM EST
ProtoKinetix Market Cap
ProtoKinetix has a market cap or net worth of $2.64 million as of January 23, 2026. Its market cap has decreased by -28.30% in one year.
Market Cap
2.64M
Enterprise Value
2.64M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since January 7, 2002, ProtoKinetix's market cap has increased from 60.38K to 2.64M, an increase of 4,279.95%. That is a compound annual growth rate of 17.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 2.64M | 8.60% |
| Dec 31, 2025 | 2.43M | -34.52% |
| Dec 31, 2024 | 3.72M | -43.47% |
| Dec 29, 2023 | 6.58M | -22.09% |
| Dec 30, 2022 | 8.44M | -71.61% |
| Dec 31, 2021 | 29.74M | 5.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enzon Pharmaceuticals | 3.72M |
| Vaccinex | 3.57M |
| AXIM Biotechnologies | 3.06M |
| Enzolytics | 2.90M |
| Sorrento Therapeutics | 2.45M |
| Agentix | 2.00M |
| Carisma Therapeutics | 1.87M |
| Galera Therapeutics | 1.82M |